A detailed history of West Financial Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, West Financial Advisors, LLC holds 5 shares of OGN stock, worth $95. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 5 -0.0%
Holding current value
$95
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$13.78 - $18.8 $1,584 - $2,162
-115 Reduced 95.83%
5 $0
Q2 2022

Jul 14, 2022

SELL
$31.66 - $38.9 $253 - $311
-8 Reduced 6.25%
120 $4,000
Q3 2021

Oct 13, 2021

SELL
$28.63 - $35.64 $858 - $1,069
-30 Reduced 18.99%
128 $4,000
Q2 2021

Jul 27, 2021

BUY
$28.45 - $38.0 $4,495 - $6,004
158 New
158 $5,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.87B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track West Financial Advisors, LLC Portfolio

Follow West Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Financial Advisors, LLC with notifications on news.